Jin Medical International Ltd.
ZJYL
$0.5852
$0.00581.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.43% | 15.98% | 18.57% | 9.62% | 0.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.43% | 15.98% | 18.57% | 9.62% | 0.74% |
| Cost of Revenue | 11.43% | 9.75% | 8.06% | 3.20% | -1.53% |
| Gross Profit | 17.06% | 27.39% | 37.98% | 21.80% | 5.17% |
| SG&A Expenses | 48.40% | 63.67% | 83.89% | 68.58% | 51.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 26.87% | -11.09% | -40.44% | -31.93% | -23.52% |
| Total Operating Expenses | 17.26% | 17.21% | 17.16% | 10.63% | 4.15% |
| Operating Income | -15.90% | 7.74% | 26.91% | 3.67% | -19.42% |
| Income Before Tax | -32.65% | -1.61% | 29.85% | 11.86% | -5.00% |
| Income Tax Expenses | 5.75% | 56.30% | 122.29% | 127.30% | 136.35% |
| Earnings from Continuing Operations | -38.77% | -9.66% | 18.82% | 1.81% | -13.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -23.83% | 261.47% | -- | -- | -- |
| Net Income | -38.30% | -5.45% | 27.71% | 7.45% | -10.51% |
| EBIT | -15.90% | 7.74% | 26.91% | 3.67% | -19.42% |
| EBITDA | -13.78% | 7.63% | 25.32% | 1.95% | -20.53% |
| EPS Basic | -38.71% | -10.31% | 15.84% | -4.98% | -22.50% |
| Normalized Basic EPS | -32.35% | -0.72% | 29.58% | 5.26% | -15.00% |
| EPS Diluted | -38.71% | -10.31% | 15.84% | -4.98% | -22.50% |
| Normalized Diluted EPS | -32.35% | -0.72% | 29.58% | 5.26% | -15.00% |
| Average Basic Shares Outstanding | 0.53% | 4.04% | 7.81% | 11.40% | 15.26% |
| Average Diluted Shares Outstanding | 0.53% | 4.04% | 7.81% | 11.40% | 15.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |